Yüklüyor......

Effect of medroxyprogesterone on depressive symptoms in depressed and non-depressed perimenopausal and postmenopausal women following discontinuation of transdermal estradiol therapy

OBJECTIVES: Concern about adverse effects of progestins on mood has influenced the use of medroxyprogesterone (MPA) and other progestins. In this brief report, we examined whether administration of MPA leads to depressive symptoms in two groups of peri- and postmenopausal women randomly assigned to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rogines-Velo, Maria Pia, Heberle, Amy E, Joffe, Hadine
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433046/
https://ncbi.nlm.nih.gov/pubmed/22027945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/gme.0b013e3182333847
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!